Introduction {#Sec1}
============

The amiloride sensitive epithelial sodium channel (ENaC) is expressed in many sodium absorbing epithelia like the aldosterone sensitive distal nephron (ASDN), distal colon, respiratory and alveolar epithelia, and the ducts of salivary and sweat glands \[[@CR15], [@CR16], [@CR24], [@CR50]\]. It mediates the critical step of passive sodium influx across the apical membrane, followed by active extrusion of sodium by the Na^+^/K^+^-ATPase across the basolateral membrane. The importance of regulating ENaC activity in principal cells of the ASDN for long-term regulation of arterial blood pressure is evidenced by two genetic diseases that affect ENaC function and arterial blood pressure: Liddle's syndrome (pseudohyperaldosteronism) \[[@CR32], [@CR39], [@CR67]\] and pseudohypoaldosteronism type 1 (PHA-1) \[[@CR6]\]. ENaC is a member of the ENaC/DEG ion channel family \[[@CR22]\]. It is composed of three homologous subunits (α-, β-, γ-ENaC) which most likely form a heterotrimer \[[@CR40], [@CR62]\]. Each subunit consists of two transmembrane domains, a large extracellular domain and intracellular N- and C-termini \[[@CR16], [@CR22]\]. The extracellular domains of α- and γ-ENaC are important for channel activation. Proteolytic cleavage of these domains by serine proteases is thought to release inhibitory peptides which increases channel open probability (*Po*) \[[@CR14], [@CR23], [@CR51]\]. The C-terminus of each ENaC subunit is important for channel internalization. The E3 ubiquitin ligase Nedd4-2 interacts with a PY-motif present at the C-terminus of each subunit and facilitates ubiquitination of the channel which marks it for endocytosis and subsequent degradation \[[@CR11], [@CR12], [@CR29], [@CR36], [@CR49], [@CR61], [@CR69]\]. The main hormonal regulator of ENaC, aldosterone, mediates its stimulatory effect on Na^+^ reabsorption in the ASDN in part via this pathway. Aldosterone increases expression of the serum and glucocorticoid-inducible kinase 1 (Sgk1) which phosphorylates Nedd4-2, thereby reducing the interaction of Nedd4-2 with the PY-motif \[[@CR9], [@CR60]\]. This reduces ENaC endocytosis and increases the number of ENaCs at the plasma membrane. Stimulating forward trafficking of ENaC is another way of increasing the number of channels at the plasma membrane and is likely to contribute to the stimulatory effect of aldosterone on ENaC \[[@CR13]\]. However, in contrast to the detailed knowledge on regulation of ENaC endocytosis, knowledge on the mechanism and regulation of ENaC forward trafficking is still limited.

As a part of the SNARE (soluble *N*-ethylmaleimide sensitive factor attachment protein receptor) machinery, syntaxins are involved in membrane fusion processes. Together with SNAP(soluble *N*-ethylmaleimide sensitive factor attachment protein)-25 or SNAP-23, they form the target membrane associated t-SNARE complex, which interacts together with vesicle associated v-SNARE proteins, like synaptobrevin or other VAMPs (vesicle associated membrane proteins) to form the SNARE core complex \[[@CR19], [@CR20], [@CR64]\]. The syntaxin family consists of 15 genes in mammals \[[@CR64]\]. The first identified members, syntaxin 1A and 1B, are localized in the presynaptic plasma membrane of neuronal and secretory cells and are involved in neurotransmission and neurosecretion. In contrast, syntaxins 2, 3, and 4 are localized at the plasma membrane of various cell types and have been implicated in various processes involving the delivery of trans-Golgi network cargo to the cell surface \[[@CR64]\]. In ENaC expressing tubular cells of rat kidney, RNA expression of syntaxin 1A and 1B is negligible, whereas RNA expression of syntaxin 4 in ASDN is comparable to that of γ-ENaC (database of nephron segment-specific transcriptomes \[[@CR30]\]). RNA expression of syntaxin 3 is approximately a fifth of that of syntaxin 4 in cortical collecting duct (CCD) \[[@CR30]\]. Endogenous protein expression of syntaxin 3 and syntaxin 4 has been detected in different segments of the rat nephron including the ASDN, the site of ENaC expression in kidney \[[@CR3], [@CR31], [@CR34], [@CR37], [@CR38]\]. Conflicting data have been reported regarding the apical versus basolateral expression pattern of syntaxin 3 and syntaxin 4 in renal epithelial cells \[[@CR3], [@CR31], [@CR37], [@CR38]\]. In transfected MDCK cells, the plasma membrane localization of syntaxin 3 was found to be restricted to the apical membrane, whereas syntaxin 4 was localized basolaterally \[[@CR34]\]. In contrast, widespread basolateral expression of syntaxin 3 \[[@CR3], [@CR38]\] has been reported in native rat renal epithelia. Moreover, apical \[[@CR37], [@CR38]\] and basolateral \[[@CR31]\] syntaxin 4 expression has been described in rat renal epithelial cells. The latter study also reported syntaxin 2 expression at the basolateral membrane of principal cells of connecting tubule (CNT) and CCD \[[@CR31]\]. Taken together, the presently available data suggest that syntaxin 2, syntaxin 3, and syntaxin 4 are expressed in renal epithelial cells of the ASDN. In case of an apical co-localization with ENaC, syntaxins may directly interact with the channel and modulate its function. Alternatively, they may have indirect effects on ENaC for example by affecting channel sorting and trafficking.

Asymmetric expression of transport proteins in polarized epithelial cells is an important precondition for transepithelial vectorial transport of substrates. However, it is still an enigma how polarized epithelial cells can achieve directed membrane trafficking of transport proteins to either the apical or basolateral membrane. Syntaxins are thought to play an important role in polarized membrane trafficking of transport proteins \[[@CR35]\]. Polarized expression of syntaxins that either mediate or inhibit fusion of vesicles carrying distinct membrane proteins could favor directed delivery of vesicles and their cargo to either the apical or basolateral membrane. Interestingly, contradictory effects of syntaxins on ENaC function have been described in heterologous expression systems. For example, stimulatory and inhibitory effects of overexpressed syntaxin 1A have been reported in HT29 cells \[[@CR55], [@CR56]\]. Co-expression of ENaC and syntaxin 1A in *Xenopus laevis* oocytes reduced ENaC function \[[@CR7], [@CR43], [@CR44], [@CR54]\], whereas syntaxin 2 had no effect \[[@CR43]\]. Syntaxin 3 stimulated ENaC function in one study \[[@CR54]\] but had no effect in others \[[@CR43], [@CR44]\]. Some of the discrepant findings reported in the literature may be due to species differences. Surprisingly, the effect of syntaxin 4 on ENaC function has not yet been investigated. Moreover, the molecular mechanisms by which syntaxins affect ENaC function remain to be elucidated. It has been reported that syntaxin 1A interacts with cytosolic termini of ENaC \[[@CR2], [@CR7], [@CR44], [@CR54]\]. Interestingly, modifying the cytosolic termini of ENaC has been shown to affect proteolytic cleavage of extracellular regions of the α- and γ-subunit \[[@CR27], [@CR28], [@CR52], [@CR53]\]. Thus, syntaxins may alter ENaC function by modulating proteolytic ENaC activation.

The aim of the present study was to revisit some of the unresolved issues of ENaC/syntaxin interaction. To investigate their effects on ENaC function, syntaxins 2, 3, and 4 were co-expressed with rat or human ENaC in *Xenopus laevis* oocytes. Effects on ENaC-mediated whole-cell currents, channel expression at the cell surface, and on proteolytic channel activation were studied.

Methods {#Sec2}
=======

Chemicals and solutions {#FPar1}
-----------------------

Unless stated otherwise, chemicals were from Sigma (Taufkirchen, Germany). Collagenase type II (CLS II) was obtained from Biochrom (Berlin, Germany). The solutions used were as follows: OR2 for isolation of oocytes (in mM: NaCl 82.5, KCl 2, MgCl~2~ 1, HEPES 5, pH 7.4 with NaOH), a low Na^+^ containing solution for oocyte incubation (in mM: NMDG-Cl 87, NaCl 9, KCl 2, CaCl~2~ 1.8, MgCl~2~ 1, HEPES 5, penicillin 100 U/ml, streptomycin 100 μg/ml, pH 7.4 with Tris), and ND96 as bath solution for two-electrode voltage-clamp experiments (in mM: NaCl 96, KCl 2, CaCl~2~ 1.8, MgCl~2~ 1, HEPES 5, pH 7.4 with Tris).

Plasmids {#FPar2}
--------

Full-length cDNAs for rat α-, β-, γ-ENaC, and a rat β-ENaC mutant carrying a FLAG-epitope in the extracellular loop were in pGEM-HE and were kindly provided by Dr. Bernard Rossier and Dr. Laurent Schild (Lausanne, Switzerland). Human α-, β-, and γ-ENaC were in pcDNA3.1 and were kindly provided by Dr. Harry Cuppens and Dr. Jean-Jacques Cassiman (Leuven, Belgium). Rat syntaxins 2, 3, and 4 were kindly provided by Dr. Mike Edwardson (Cambridge, UK) and were subcloned into pTLN vector \[[@CR33]\] which was kindly provided by Dr. Thomas Jentsch (Berlin, Germany). Human dominant-negative Rab11a was in pcDNA3.1. It carried a S25N mutation for inactivation and was kindly provided by Dr. Guiscard Seebohm (Bochum, Germany). Linearized plasmids were used as templates for cRNA synthesis (mMessage mMachine, Ambion, Austin, TX, USA) using T7 or SP6 as promotor.

Isolation of oocytes and injection of cRNA {#FPar3}
------------------------------------------

Defolliculated stage V-VI oocytes were obtained from ovarian lobes of adult female *Xenopus laevis* in accordance with the principles of German legislation, with approval by the animal welfare officer for the University of Erlangen-Nürnberg (FAU) and under the governance of the state veterinary health inspectorate \[[@CR29], [@CR46], [@CR47]\]. Animals were anesthetized in 0.2% MS222, and ovarian lobes were excised by partial ovariectomy. Oocytes were isolated by enzymatic digestion at 19 °C for 3--4 h with 600--700 U/ml collagenase type II dissolved in OR2 solution. cRNAs were dissolved in RNase-free water and a volume of 46 nl was injected into stage V-VI oocytes with a Nanoject II automatic injector (Drummond, Broomall, PA). Amount and type of injected cRNA are specified in the figure legends. cRNAs for the three subunits (αβγ) of ENaC were routinely co-injected using 0.01, 0.025, or 0.05 ng per subunit per oocyte for rat ENaC (rENaC) and 0.2 ng per subunit per oocyte for human ENaC (hENaC). Injected oocytes were kept in a low Na^+^ containing solution to prevent Na^+^ overloading of ENaC expressing oocytes which would reduce ENaC cell surface expression \[[@CR26], [@CR65]\]. The incubation solution was supplemented with 100 U/ml Na^+^-penicillin and 100 μg/ml streptomycin sulfate to prevent bacterial growth.

Two-electrode voltage-clamp {#FPar4}
---------------------------

Two days after cRNA injection, whole-cell currents were measured with an OC-725C two-electrode voltage-clamp amplifier (Warner Instruments, Hamden, CT) at a holding potential of − 60 mV \[[@CR29], [@CR46], [@CR47]\]. The amplifier was connected to a PC via a LIH-1600 interface (HEKA, Lambrecht, Germany) and controlled by PULSE software (HEKA) for data acquisition and analysis. During the measurements, oocytes were constantly superfused (2--3 ml/min) with ND96 at room temperature (20--21 °C). Bath solution exchanges were controlled by an ALA BPS-8 magnetic valve system in combination with a TIB14 interface (both HEKA). By convention, inward whole-cell currents evoked by influx of cations or efflux of anions are represented as negative currents. Amiloride-sensitive whole-cell current (Δ*I*~ami~) was determined by subtracting the whole-cell current measured in the absence of amiloride from that measured in the presence of amiloride (2 μM).

Surface Labelling {#FPar5}
-----------------

ENaC surface expression was determined using a chemiluminescence assay and a rat β~FLAG~ENaC construct with a FLAG reporter epitope inserted into its extracellular domain as described previously \[[@CR10], [@CR25], [@CR45], [@CR48], [@CR68]\]. All steps were performed on ice and no glassware was used. Unspecific binding sites were blocked by 30 min incubation in ND96 supplemented with 1% bovine serum albumin (BSA). Subsequently, oocytes were incubated for 1 h in primary mouse anti-FLAG M2 monoclonal antibody (1 μg/ml, Sigma, Taufkirchen, Germany), washed 6 × 3 min in ND96 + BSA, incubated for 45 min in secondary peroxidase-conjugated sheep anti-mouse IgG (1:400, Chemicon, Boronia Victoria, Australia), washed 6 × 3 min in ND96 + BSA, and finally 6 × 3 min in ND96. Individual oocytes were placed in a white U-bottom 96-well plate, and 50 μl of SuperSignal ELISA Femto Maximum Sensitivity Substrate (Pierce, Rockford, IL) was added to each oocyte. Chemiluminescence was quantified with a Tecan GENios microplate reader (TECAN, Crailsheim, Germany).

Statistics {#Sec3}
----------

Data are presented as mean ± SEM and were analyzed using GraphPad Prism 5.04 for Windows (GraphPad Software Inc., San Diego, CA, USA). Statistical significance was assessed by appropriate versions of Student's *t* test or ANOVA. Figures in columns indicate number of measured oocytes; *N* indicates the number of different batches of oocytes.

Results {#Sec4}
=======

Syntaxins 3 and 4 stimulate rENaC but syntaxin 2 does not {#Sec5}
---------------------------------------------------------

To investigate the effects of syntaxins 2, 3, and 4 on rat ENaC function, *Xenopus laevis* oocytes were injected with cRNA for rENaC alone or in combination with different amounts of cRNA for syntaxins 2, 3, or 4. After 2 days of incubation, amiloride-sensitive whole-cell currents (Δ*I*~ami~) were measured with the two-electrode voltage-clamp technique. Figure [1a](#Fig1){ref-type="fig"} shows representative whole-cell current traces from an oocyte expressing rENaC alone and from an oocyte co-expressing rENaC and syntaxin 2 (1 ng cRNA). Average data from similar experiments using oocytes from the same batch are shown in Fig. [1b](#Fig1){ref-type="fig"}. Normalized data from different batches of oocytes using different amounts of injected cRNA for syntaxin 2 are summarized in Fig. [1c](#Fig1){ref-type="fig"}. Taken together, the experiments shown in Fig. [1a--c](#Fig1){ref-type="fig"} revealed no significant effect of syntaxin 2 co-expression on ENaC currents which is in agreement with a previous report \[[@CR43]\]. In contrast to syntaxin 2, co-expression of syntaxin 3 (1 ng cRNA) stimulated Δ*I*~ami~ (Fig. [1d, e](#Fig1){ref-type="fig"}). Interestingly, a significant stimulatory effect of syntaxin 3 was only observed in experiments with 1 ng of injected cRNA for syntaxin 3 but not with lower or higher amounts (Fig. [1f](#Fig1){ref-type="fig"}). On average, co-injection of 1 ng of cRNA for syntaxin 3 increased rENaC currents by 50% compared to Δ*I*~ami~ measured in corresponding control oocytes injected with cRNA for rENaC alone. Co-injection of cRNA for syntaxin 4 (0.33, 1, or 3 ng) also significantly increased Δ*I*~ami~ (Fig. [1g--i](#Fig1){ref-type="fig"}) with a maximal average stimulation of 135% observed with 1 ng of cRNA.Fig. 1Syntaxins 3 and 4 stimulate rENaC function in oocytes. Oocytes were injected with cRNA for rENaC alone or together with different amounts of cRNA for syntaxin 2 (+STX2), syntaxin 3 (+STX3), or syntaxin 4 (+STX4) and incubated for 2 days. Amiloride-sensitive whole-cell currents (Δ*I*~ami~) were measured with the two-electrode voltage-clamp technique. **a**, **d**, **g** Representative whole-cell current traces from matched control oocytes expressing rENaC alone or from oocytes co-expressing rENaC and a syntaxin isoform (1 ng cRNA), as indicated. The presence of amiloride (ami) in the bath solution is indicated by black bars. **b**, **e**, **h** Summary of data obtained from an individual batch of oocytes measured as shown in **a**, **d**, or **g**, respectively. **c**, **f**, **i** Summary of data as shown in **b**, **e**, and **h** obtained from several different batches of oocytes. To take batch-to-batch variability into account, individual Δ*I*~ami~ values were normalized to the mean Δ*I*~ami~ of the rENaC control group of the corresponding batch. Unpaired *t* test (**b**, **e**, **h**) or one-way ANOVA followed by Dunnett's multiple comparison test vs. rENaC control (**c**, **f**, **i**), \* *p* \< 0.05, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001

hENaC is stimulated by syntaxin 3 but not by syntaxins 2 and 4 {#Sec6}
--------------------------------------------------------------

To investigate whether syntaxins also affect human ENaC, we measured whole-cell currents from oocytes expressing hENaC alone or co-expressing hENaC and syntaxin 2, 3, or 4. As summarized in Fig. [2b](#Fig2){ref-type="fig"}, co-expression of syntaxin 3 (1 ng cRNA) stimulated human ENaC to a similar extent (48%) as rat ENaC. There was a non-significant stimulatory trend with 0.1 and 0.33 ng cRNA for syntaxin 3, but no appreciable effect with 3 ng. Interestingly, co-injection of cRNA for syntaxin 2 (0.33, 1, or 3 ng; Fig. [2a](#Fig2){ref-type="fig"}) or syntaxin 4 (0.33, 1, or 3 ng; Fig. [2c](#Fig2){ref-type="fig"}) had a significant inhibitory effect on hENaC. The inhibitory effect was most pronounced with 3 ng cRNA with a 51% inhibition by syntaxin 2 and a 44% inhibition by syntaxin 4. The inhibitory effects of syntaxin 2 and syntaxin 4 on hENaC differ from the findings with rENaC shown above. Thus, effects of different syntaxin isoforms on ENaC may be species dependent. This may explain some of the controversial findings reported in the literature. The preserved stimulatory effect of syntaxin 3 on human ENaC makes syntaxin 3 a particularly interesting candidate for further studies.Fig. 2Effects of syntaxins 2, 3, and 4 on hENaC function. Oocytes were injected with cRNA for hENaC alone or together with different amounts of cRNA for syntaxin 2 (+STX2, **a**), syntaxin 3 (+STX3, **b**), or syntaxin 4 (+STX4, **c**). To take batch-to-batch variability into account, individual Δ*I*~ami~ values were normalized to the mean Δ*I*~ami~ of the hENaC control group of the corresponding batch. One-way ANOVA followed by Dunnett's multiple comparison test vs. hENaC control, \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001

Syntaxins 3 and 4 increase rENaC expression at the cell surface {#Sec7}
---------------------------------------------------------------

Syntaxins are involved in vesicle fusion processes. Therefore, we hypothesized that the stimulatory effect of syntaxin 3 and syntaxin 4 on rENaC function is caused by an increase of channel expression at the cell surface. To investigate this hypothesis, we detected rENaC expression at the cell surface of rENaC expressing oocytes with a chemiluminescence based assay in the presence and absence of syntaxin 3 or syntaxin 4. For channel detection at the cell surface, a FLAG reporter epitope was inserted in the extracellular domain of the β-rENaC subunit. As positive control for increased channel surface expression, an additional group of oocytes was injected with twice the amount of cRNA for rENaC and was studied in parallel in every set of experiments. Δ*I*~ami~ was measured in matched groups of oocytes from the same batches as used for the detection of rENaC surface expression. Doubling the amount of injected cRNA for rENaC increased Δ*I*~ami~ by about 2-fold and the corresponding chemiluminescence signal by about 4-fold (Fig. [3](#Fig3){ref-type="fig"}). Thus, the relative increase in chemiluminescence is larger than that of the corresponding ENaC currents. Nevertheless, these control experiments confirmed the suitability of the chemiluminescence assay to detect an increase in ENaC surface expression in a semiquantitative manner. Co-expression of rENaC and syntaxin 3 increased Δ*I*~ami~ 1.4-fold and surface expression 1.9-fold compared to oocytes expressing rENaC alone. Similarly, syntaxin 4 increased Δ*I*~ami~ and surface expression 1.5-fold and 3.2-fold, respectively. Taken together, these data suggest that the stimulatory effects of syntaxin 3 and syntaxin 4 can be attributed at least in part, if not fully, to an increase of rENaC surface expression.Fig. 3Syntaxins 3 and 4 increase surface expression of rENaC. Δ*I*~ami~ (**a**) and surface expression (**b**) were measured in parallel in oocytes expressing rENaC carrying a FLAG reporter epitope in the extracellular domain of the β-subunit (rENaC~FLAG~) alone or together with syntaxin 3 (+STX3) or syntaxin 4 (+STX4). Oocytes injected with twice the amount of cRNA for rENaC~FLAG~ (rENaC~FLAG~ 2×) served as positive control. In three batches of oocytes, oocytes were injected with 0.025 ng cRNA/subunit for rENaC~FLAG~ and with 1 ng cRNA for syntaxin 3 or syntaxin 4. In five batches of oocytes, oocytes were injected with 0.05 ng cRNA/subunit for rENaC~FLAG~ and with 2 ng cRNA for syntaxin 3 or syntaxin 4. To summarize data from different batches of oocytes, values were normalized to the mean of the corresponding rENaC~FLAG~ control group. One-way ANOVA followed by Dunnett's multiple comparison test vs. rENaC~FLAG~ control, \*\**p* \< 0.01, \*\*\**p* \< 0.001

Syntaxins 3 and 4 do not affect proteolytic activation of rENaC by chymotrypsin {#Sec8}
-------------------------------------------------------------------------------

To investigate a possible effect of syntaxin 3 and syntaxin 4 on proteolytic ENaC activation, we expressed rENaC alone or together with syntaxin 3 or syntaxin 4 in oocytes and measured Δ*I*~ami~ before and after proteolytic activation of ENaC with chymotrypsin, which maximizes channel *Po* \[[@CR17], [@CR46], [@CR47]\]. After maximizing *Po*, differences in Δ*I*~ami~ are largely independent of *Po* and therefore reflect differences of channel surface expression. In addition, the ratio of Δ*I*~ami~ before and after rENaC activation is a good estimate of average rENaC *Po* prior to activation. Figure [4a and d](#Fig4){ref-type="fig"} show representative whole-cell current traces from individual oocytes to illustrate the experimental protocol and key findings. All experiments were started in the presence of amiloride. Δ*I*~ami-initial~ was determined from the new steady state whole-cell current reached after washout of amiloride. Subsequently, chymotrypsin was added to the bath solution. The increase of the inward whole-cell current reflects proteolytic channel activation. After the whole-cell current had reached a new steady state, amiloride was re-applied and Δ*I*~ami-chymo~ was determined. As expected, baseline ENaC currents (Δ*I*~ami-initial~) were larger in oocytes co-expressing syntaxin 3 (Fig. [4a, b](#Fig4){ref-type="fig"}) or syntaxin 4 (Fig. [4d, e](#Fig4){ref-type="fig"}) compared to the corresponding control oocytes. Thus, these experiments confirmed the stimulatory effect of syntaxin 3 and syntaxin 4 on ENaC shown above. Consistent with the increased baseline ENaC currents, application of chymotrypsin increased ENaC currents to higher absolute values in oocytes co-expressing syntaxin 3 or syntaxin 4 compared to those reached in the corresponding control oocytes expressing rENaC alone (Fig. [4b, e](#Fig4){ref-type="fig"}). Importantly, the relative stimulatory effect of chymotrypsin on ENaC currents in control oocytes was not significantly different from that in oocytes co-expressing syntaxin 3 (4.7-fold vs. 4.1-fold) or syntaxin 4 (4.2-fold vs. 3.6-fold). Moreover, neither syntaxin 3, nor syntaxin 4 showed significant effects on the ratio of Δ*I*~ami-initial~ and Δ*I*~ami-chymo~ (Fig. [4c, f](#Fig4){ref-type="fig"}) which suggests that the effects of syntaxin 3 and syntaxin 4 on rENaC *Po* are negligible. In summary, these results confirm the conclusion from the chemiluminescence experiments (see above) and support the hypothesis that syntaxin 3 and syntaxin 4 stimulated rENaC function mainly by increasing channel surface expression without a major effect on *Po*.Fig. 4Syntaxins 3 and 4 do not affect proteolytic activation of rENaC by chymotrypsin. Oocytes were injected with cRNA for rENaC (0.025 ng/subunit) alone or together with cRNA for syntaxin 3 (STX3, 1 ng) or syntaxin 4 (STX4, 1 ng) and incubated for 2 days. **a**, **d** Typical whole-cell current traces of oocytes expressing rENaC alone or together with syntaxin 3 (**a**) or syntaxin 4 (**d**). **b**, **e** Summary of Δ*I*~ami~ values before and after activation of rENaC with chymotrypsin (2 μg/ml) obtained from similar experiments as shown in **a** and **d**, respectively. Δ*I*~ami~ values before and after application of chymotrypsin were compared with paired *t* test; corresponding Δ*I*~ami~ values in the absence and presence of syntaxin 3 or syntaxin 4 were compared with unpaired *t* test. **c**, **f** Ratio of Δ*I*~ami~ before (Δ*I*~ami-initial~) and after (Δ*I*~ami-chymo~) activation of rENaC with chymotrypsin was calculated from individual oocytes as a measure of average channel *Po*; unpaired *t* test. *n.s.* not significant, \*\**p* \< 0.01, \*\*\**p* \< 0.001

Syntaxin 3 stimulates rENaC insertion into the plasma membrane {#Sec9}
--------------------------------------------------------------

The stimulatory effect of syntaxin 3 on rENaC surface expression can be caused by a stimulation of channel insertion into the plasma membrane or by an inhibition of channel retrieval. To investigate by which of these mechanisms syntaxin 3 stimulates channel surface expression, we blocked channel delivery from the Golgi apparatus to the plasma membrane by brefeldin A \[[@CR42], [@CR59]\]. Blocking channel delivery to the plasma membrane decreases rENaC surface expression and thus Δ*I*~ami~. If syntaxin 3 stimulated channel insertion into the plasma membrane, it is not expected to affect the inhibitory effect of brefeldin A on Δ*I*~ami~. In contrast, if syntaxin 3 inhibited channel retrieval, it is likely to diminish the inhibitory effect of brefeldin A. Co-expression of syntaxin 3 stimulated Δ*I*~ami~ at 0 h baseline by 119% (Fig. [5](#Fig5){ref-type="fig"}), which confirms the stimulatory effect of syntaxin 3 on rENaC in the experiments performed with brefeldin A. Incubating the oocytes in the presence of brefeldin A reduced Δ*I*~ami~ in oocytes with and without co-expression of syntaxin 3 consistent with an inhibition of anterograde channel trafficking. In contrast, in time-matched control oocytes incubated in the absence of brefeldin A, Δ*I*~ami~ continuously increased over 8 h indicating ongoing channel insertion. Importantly, in oocytes expressing rENaC alone or rENaC and syntaxin 3, brefeldin A reduced Δ*I*~ami~ by 68% and 62%, respectively, compared to corresponding control oocytes incubated in the absence of brefeldin A. Thus, the inhibitory effect of brefeldin A was preserved in oocytes co-expressing syntaxin 3 which argues against an effect of syntaxin 3 on channel retrieval. After brefeldin A was removed from the incubation medium, Δ*I*~ami~ increased in all experimental groups at a similar rate which confirmed that the oocytes remained viable. In summary, these results suggest that syntaxin 3 stimulates rENaC insertion into the plasma membrane.Fig. 5Syntaxin 3 stimulates rENaC insertion into the plasma membrane. Oocytes were injected with cRNA for rENaC (0.025 ng/subunit) alone or together with cRNA for syntaxin 3 (1 ng) and incubated for 2 days. After the initial measurement of Δ*I*~ami~ at 0 h, half of the oocytes were incubated for 8 h in the presence of brefeldin A (BFA, 5 μM), as indicated, and Δ*I*~ami~ was measured at 4, 8, and 24 h. Each data point represents Δ*I*~ami~ values from 28 to 30 oocytes. For better comparison, Δ*I*~ami~ was normalized to the rENaC expressing control group

Blocking endosomal recycling does not prevent the stimulation of rENaC by syntaxin 3 {#Sec10}
------------------------------------------------------------------------------------

rENaC expression at the plasma membrane can be increased by stimulating fusion of vesicles carrying newly synthesized channels from the Golgi apparatus or by recycling endosomes to the plasma membrane which results in the reinsertion of previously endocytosed rENaC. The small G protein Rab11a has been shown to be involved in the regulation of ENaC trafficking by endosomal recycling \[[@CR5], [@CR21]\]. If the stimulatory effect of syntaxin 3 on rENaC is mediated by increased endosomal recycling, blocking this pathway is expected to reduce the stimulatory effect of syntaxin 3. To test this hypothesis, we expressed rENaC alone or together with syntaxin 3 and/or dominant-negative Rab11a (dnRab11a) in oocytes. Compared to rENaC expressing control oocytes, co-expression of syntaxin 3 stimulated Δ*I*~ami~ by 74% which confirms the stimulatory effect of syntaxin 3 in this set of experiments. Co-expression of rENaC and dnRab11a reduced Δ*I*~ami~ by 47% (Fig. [6](#Fig6){ref-type="fig"}) which indicates the inhibitory effect of dnRab11a on endosomal recycling. Co-expression of rENaC, dnRab11a, and syntaxin 3 increased Δ*I*~ami~ by 91% compared to oocytes co-expressing rENaC and dnRab11a. Thus, blocking endosomal recycling by dnRab11a did not prevent the stimulatory effect of syntaxin 3. These results support the conclusion that syntaxin 3 increases rENaC expression at the cell surface probably by enhancing the insertion of vesicles carrying newly synthesized channels.Fig. 6Blocking endosomal recycling does not prevent the stimulation of rENaC by syntaxin 3. Oocytes were injected with cRNA for rENaC (0.025 ng/subunit) alone or together with cRNA for dominant-negative Rab11a (5 ng, +dnRab11a), syntaxin 3 (1 ng, +STX3), or both. Δ*I*~ami~ was measured after 2 days of incubation. One-way ANOVA followed by Bonferroni's multiple comparison test with selected pairs, \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001

Discussion {#Sec11}
==========

In the present study, we report for the first time that syntaxin 4 stimulates rENaC function. The stimulatory effect could be attributed to an increase of rENaC surface expression, whereas average *Po* of rENaC was not altered by syntaxin 4. In contrast to its effect on rENaC, syntaxin 4 inhibited hENaC. It is tempting to speculate that subtle species differences may be responsible for the opposite effects of rat syntaxin 4 on rENaC and hENaC. Importantly, the observed opposite effects argue against a nonspecific action of syntaxin 4 in the oocyte expression system, because this would be expected to affect rENaC and hENaC in a similar manner.

Syntaxin 3 consistently stimulated rENaC and hENaC in the present study. This is an observation with potential physiological relevance, because syntaxin 3 may be co-expressed with ENaC in the apical membrane of renal tubular cells in the ASDN. This stimulatory effect of syntaxin 3 was consistently observed in experiments with 1 ng of injected syntaxin 3 cRNA. Interestingly, with a higher amount of cRNA, the stimulatory effect was not enhanced but disappeared. A similar phenomenon has previously been reported for syntaxin 1A in human HT29 colonic epithelial cells, which endogenously express ENaC \[[@CR56]\]. The authors speculated that higher expression of syntaxin 1A may have reduced stimulation as a consequence of overdose. Interestingly, the N-terminus of some syntaxins is able to reversibly associate with their own H3 domain which prevents the formation of the SNARE core complex \[[@CR20], [@CR64]\]. It is conceivable that, as an unspecific effect, the N-terminus of overexpressed syntaxins may interact with the H3 domains of endogenous syntaxins or of other overexpressed syntaxins, thereby inhibiting the formation of the SNARE core complex. This could explain the overdose effect. In this context, it is interesting to mention that overexpression of syntaxin 1A in HT29 cells stimulated endogenous ENaC, whereas overexpression of isolated H3 domains of syntaxin 1A inhibited ENaC \[[@CR56]\].

The stimulatory effect of syntaxin 3 on rENaC seen in the present study can be attributed to an increase of rENaC surface expression, whereas average *Po* of rENaC does not seem to be altered by syntaxin 3. In agreement with our data, a previous study performed in oocytes also reported an increase of rENaC surface expression induced by syntaxin 3 \[[@CR54]\]. In contrast, another study found no effect of syntaxin 3 on hENaC surface expression and Δ*I*~ami~ \[[@CR44]\]. We do not know the reason for this discrepancy. However, considering the dose dependent effect seen in the present study with different amounts of injected cRNA for syntaxin 3, the effective dose may have been missed in the latter study.

An increase of channel expression at the cell surface can be the result of an increased fusion of trafficking vesicles with the plasma membrane or of an inhibition of channel retrieval. To distinguish between these mechanisms, we incubated oocytes expressing rENaC alone or together with syntaxin 3 in the presence of brefeldin A, a fungal metabolite which blocks channel delivery from the Golgi apparatus to the plasma membrane \[[@CR42]\]. This method has previously been used in several studies with *Xenopus laevis* oocytes \[[@CR1], [@CR26], [@CR41], [@CR44], [@CR59], [@CR65]\]. In the present study, the inhibitory effect of brefeldin A on Δ*I*~ami~ was preserved in the presence of syntaxin 3. This result suggests that syntaxin 3 does not inhibit channel retrieval but stimulates channel insertion. Delivery of ENaC to the plasma membrane may be directly from the Golgi apparatus, from the recycling pathway or from stored vesicles \[[@CR4], [@CR66]\]. The relative importance of these delivery pathways is likely to be regulated according to physiological needs and probably varies in different tissues and cellular expression systems. For example, internalized ENaC showed poor recycling in MDCK cells under baseline conditions, whereas ENaC recycling was strongly enhanced by long-term stimulation with cAMP \[[@CR36]\]. Effects of Rab11a and Rab11b on ENaC activity indicate that recycling endosomes play a role in ENaC delivery to the plasma membrane \[[@CR4], [@CR66]\]. Rab11a has been shown to increase ENaC activity in CHO cells \[[@CR21]\], and a dominant negative form of Rab11a has been shown to inhibit ENaC-dependent sodium transport in mpkCCD cells \[[@CR5]\]. To exclude that in the oocyte expression system syntaxin 3 stimulates insertion of recycling endosomes, we blocked insertion of recycling endosomes with dominant negative Rab11a. Rab11a is a small G protein (GTPase) which is expressed at the membranes of the Golgi apparatus, early endosomes, and recycling endosomes and regulates slow endocytic recycling \[[@CR18]\]. The dominant negative Rab11a mutant has previously been used in *Xenopus laevis* oocytes to prevent stimulation of KCNQ1/KCNE1 potassium channels, the AMPA-type glutamate receptor GluA1 and a kainate receptor mutant (GluR6-M836I) by blocking endosomal recycling \[[@CR57], [@CR58], [@CR63]\]. In the present study, dnRab11a reduced the function of rENaC which confirmed its inhibitory effect on endosomal recycling. Importantly, the stimulatory effect of syntaxin 3 was preserved in the presence of dnRab11a. This supports the conclusion that syntaxin 3 enhances ENaC surface expression by favoring fusion of vesicles carrying newly synthesized ENaCs with the plasma membrane and not by stimulating endosomal recycling. It should be noted that trafficking of membrane proteins in *Xenopus laevis* oocytes may differ from that in polarized epithelial cells, which is a limitation of the present study.

Serine proteases, e.g., chymotrypsin, are able to stimulate ENaC by increasing its *Po* \[[@CR14], [@CR23], [@CR51]\]. In the present study, neither syntaxin 3 nor syntaxin 4 affected proteolytic activation of rENaC by chymotrypsin. These results suggest that average *Po* of rENaC was not affected by syntaxin 3 or syntaxin 4. Previously, it has been reported that GST-syntaxin 1A fusion proteins including the H3 domain reduced ENaC *Po* in single-channel recordings from planar lipid bilayers and from *Xenopus laevis* oocytes in the cell-attached mode \[[@CR2], [@CR8]\]. Thus, the effects of syntaxin 3 and syntaxin 4 on ENaC apparently differ from that of syntaxin 1A regarding *Po*.

In summary, we have shown that syntaxin 3 and syntaxin 4 consistently stimulated rENaC function mainly by increasing channel surface expression with little effect on *Po*. Moreover, we provide evidence that syntaxin 3 stimulates rENaC by increasing the delivery of newly synthesized ENaC to the plasma membrane but not by stimulating endosomal recycling. The stimulatory effect of syntaxin 3 was confirmed for hENaC, but in contrast to its stimulatory effect on rENaC, syntaxin 4 had an inhibitory effect on hENaC. Moreover, syntaxin 2 had no detectable effect on rENaC but an inhibitory effect on hENaC. These latter findings support the hypothesis that species differences may explain some of the controversial findings reported on ENaC/syntaxin interaction in the literature. The observed stimulatory effect of syntaxin 3 may be physiologically relevant for ENaC regulation in the apical membrane of tubular cells in the ASDN where ENaC and syntaxin 3 may be colocalized.
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